Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Liam P. Fawcett, Nicholas M. Levinson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Core control principles of the eukaryotic cell cycle
10.1038/s41586-022-04798-8 · 2022
Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2
10.1128/mcb.15.1.345 · 1995
Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells
10.1016/j.molcel.2007.02.003 · 2007
p21 is a universal inhibitor of cyclin kinases
10.1038/366701a0 · 1993
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
10.1038/366704a0 · 1993
Structural insights into the functional diversity of the CDK–cyclin family
10.1098/rsob.180112 · 2018
Crystal structure of cyclin-dependent kinase 2
10.1038/363595a0 · 1993
Mechanism of CDK activation revealed by the structure of a cyclinA–CDK2 complex
10.1038/376313a0 · 1995
Structural basis of cyclin-dependent kinase activation by phosphorylation
10.1038/nsb0896-696 · 1996
Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin
10.1126/science.270.5233.90 · 1995
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles
10.1038/sj.emboj.7600554 · 2005
Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
10.1038/382325a0 · 1996
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation
10.1038/emboj.2008.121 · 2008
Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
10.1038/s41523-022-00494-y · 2022
Cryo-EM structures of the CDK11-cyclin L-SAP30BP complex reveal mechanisms of CDK11 regulation
10.1038/s41467-026-72329-4 · 2026
Speedy: a novel cell cycle regulator of the G2/M transition
10.1093/emboj/18.7.1869 · 1999
A novel p34(cdc2)-binding and activating protein that is necessary and sufficient to trigger G(2)/M progression in Xenopus oocytes
10.1101/gad.13.16.2177 · 1999
Identification and comparative analysis of multiple mammalian Speedy/Ringo proteins
10.4161/cc.4.1.1347 · 2005
Evolution of the Cdk-activator Speedy/RINGO in vertebrates
10.1007/s00018-012-1050-1 · 2012
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2
10.1083/jcb.200109045 · 2002
Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins
10.1074/jbc.m104722200 · 2001
Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins
10.15252/embj.201796905 · 2017
Biochemical characterization of Cdk2-Speedy/Ringo A2
10.1186/1471-2091-6-19 · 2005
Speedy A-Cdk2 binding mediates initial telomere-nuclear envelope attachment during meiotic prophase I independent of Cdk2 activation
10.1073/pnas.1618465114 · 2017
Substrate specificity of CDK2-cyclin A. What is optimal?
10.1074/jbc.m306546200 · 2003
Differences in binding affinity among cell-cycle CDK and cyclin pairs
10.1016/j.jmb.2025.168952 · 2025
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
10.1038/s41589-020-00725-y · 2021
Differences in the conformational energy landscape of CDK1 and CDK2 suggest a mechanism for achieving selective CDK inhibition
10.1016/j.chembiol.2018.10.015 · 2019
Characterization of a new family of cyclin-dependent kinase activators
10.1042/bj20041779 · 2005
The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases
10.1038/15674 · 1999
The SUN1-SPDYA interaction plays an essential role in meiosis prophase I
10.1038/s41467-021-23550-w · 2021
Discovery of AZD8421: a potent CDK2 inhibitor with selectivity against other CDK family members and the human kinome
10.1021/acs.jmedchem.5c01478 · 2025
Profiling the activity of the potent and highly selective CDK2 inhibitor BLU-222 reveals determinants of response in CCNE1-aberrant ovarian and endometrial tumors
10.1158/0008-5472.can-24-2360 · 2025
Human TPX2 is required for targeting Aurora-A kinase to the spindle
10.1083/jcb.200204155 · 2002
Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states
10.1073/pnas.1811158115 · 2018
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
10.1038/s41467-023-38732-x · 2023
Human and yeast cdk-activating kinases (CAKs) display distinct substrate specificities
10.1091/mbc.9.9.2545 · 1998
mtsslSuite: probing biomolecular conformation by spin-labeling studies
10.1016/bs.mie.2015.06.006 · 2015
Spectral unmixing plate reader: high-throughput, high-precision FRET assays in living cells
10.1177/1087057116679637 · 2017
How to measure and evaluate binding affinities
10.7554/elife.57264 · 2020
No additional external references are available.